References
- NevilleHLRitcheyMLWilms’ tumor. Overview of National Wilms’ Tumor Study Group resultsUrol Clin North Am200027343544210985143
- GodzinskiJThe current status of treatment of Wilms’ tumor as per the SIOP trialsJ Indian Assoc Pediatr Surg2015201162025552825
- MetzgerMLDomeJSCurrent therapy for Wilms’ tumorOncologist2005101081582616314292
- Al-HussainTAliAAkhtarMWilms’ tumor: an updateAdv Anat Pathol20142116617324713986
- EkenzeSOAgugua-ObianyoNEOdetundeOAThe challenge of nephroblastoma in a developing countryAnn Oncol200617101598160016873431
- YaoWLiKXiaoXGaoJDongKLvZOutcomes of Wilms’ tumor in eastern China: 10 years of experience at a single centerJ Invest Surg201225318118522583015
- BeckwithJBZuppanCEBrowningNGMoksnessJBreslowNEHistological analysis of aggressiveness and responsiveness in Wilms’ tumorMed Pediatr Oncol19962754224288827069
- GreenDMBeckwithJBBreslowNETreatment of children with stages II to IV anaplastic Wilms’ tumor: a report from the National Wilms’ Tumor Study GroupJ Clin Oncol19941210212621317931483
- DomeJSCottonCAPerlmanEJTreatment of anaplastic histology Wilms’ tumor: results from the fifth National Wilms’ Tumor StudyJ Clin Oncol200624152352235816710034
- LiJCheungHYZhangZChanGKFongWFAndrographolide induces cell cycle arrest at G2/M phase and cell death in HepG2 cells via alteration of reactive oxygen speciesEur J pharmacol20075681–3314417512926
- CheungMTRamalingamRLauKKChiangWLChiuSKCell type-dependent effects of andrographolide on human cancer cell linesLife Sci20129115–1675176023047020
- ChouTCTheoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studiesPharmacol Rev200658362168116968952
- LiuYYangYYeYCActivation of ERK-p53 and ERK-mediated phosphorylation of Bcl-2 are involved in autophagic cell death induced by the c-Met inhibitor SU11274 in human lung cancer A549 cellsJ Pharmacol Sci20121181442343222466960
- PhilchenkovACaspases: potential targets for regulating cell deathJ Cell Mol Med20048443244415601572
- El-KhattoutiASelimovicDHaikelYHassanMCrosstalk between apoptosis and autophagy: molecular mechanisms and therapeutic strategies in cancerJ Cell Death20136375525278778
- YangSHWangSMSyeJPAndrographolide induces apoptosis of C6 glioma cells via the ERK-p53-caspase 7-PARP pathwayBiomed Res Int2014201431284725162007
- PratheeshkumarPSheejaKKuttanGAndrographolide induces apoptosis in B16F-10 melanoma cells by inhibiting NF-κB-mediated bcl-2 activation and modulating p53-induced caspase-3 gene expressionImmunopharmacol Immunotoxicol201234114315121682651
- ZhouJLuGDOngCSShenHMAndrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulationMol Cancer Ther2008772170218018645026
- JoHMondalSTanDSmall molecule-induced cytosolic activation of protein kinase AKT rescues ischemia-elicited neuronal deathProc Natl Acad Sci U S A201210926105811058622689977
- YanFTZhiHLLiXXMolecular mechanism of the cell death induced by the histone deacetylase pan inhibitor LBH589 (Panobinostat) in Wilms tumor cellsPLoS One2015107e012656626176219
- TaoYFLuJDuXJSurvivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cellsBMC Cancer20121261923267699
- RajagopalSKumarRADeeviDSSatyanarayanaCRajagopalanRAndrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculataJ Exp Ther Oncol20033314715814641821
- JiLLiuTLiuJChenYWangZAndrographolide inhibits human hepatoma-derived Hep3B cell growth through the activation of c-Jun N-terminal kinasePlanta Med200773131397140117918040
- TsaiHRYangLMTsaiWJChiouWFAndrographolide acts through inhibition of ERK1/2 and AKT phosphorylation to suppress chemotactic migrationEur J Pharmacol20044981–3455215363974
- AbrahamAGO’NeillEPI3K/AKT-mediated regulation of p53 in cancerBiochem Soc Trans201442479880325109960
- JadaliFSayadpourDRakhshanMImmunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumorIran J Kidney Dis20115314915321525573
- GovenderDHarilalPHadleyGPChettyRp53 protein expression in nephroblastomas: a predictor of poor prognosisBr J Cancer1998773143189461003